Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N, Lin P, Danho W, Kochan J, Chizzonite R
Department of Molecular Genetics, Roche Research Center, Hoffman-LaRoche, Inc., Nutley, New Jersey 07110.
J Biol Chem. 1991 Jun 15;266(17):11245-51.
The binding of IgE to the high affinity Fc epsilon receptor (Fc epsilon RI) on mast cells and basophils is mediated by the alpha-subunit of the tetrameric receptor complex. Based on sequence homologies, the 50-kDa alpha-subunit is a member of the immunoglobulin superfamily of proteins and has two predicted disulfide-bonded loops. Monoclonal antibodies specific for the human alpha-subunit have been identified and separated into two major classes: inhibitory and noninhibitory antibodies. Inhibitory antibodies (i.e. 15A5) block 125I-IgE binding to a recombinant chimeric alpha-subunit (ch-alpha-protein) expressed on Chinese hamster ovary cells and immunoprecipitate 125I-labeled purified ch-alpha-protein. Noninhibitory antibodies (i.e. 22E7) immunoprecipitate both 125I-labeled ch-alpha-protein and the soluble complex of 125I-IgE cross-linked to ch-alpha-protein but do not block 125I-IgE binding to the ch-alpha-protein expressed on Chinese hamster ovary cells. Both classes of antibodies bind to natural Fc epsilon RI present on human basophils and induce histamine release from these cells. Inhibitory antibody 15A5 specifically binds to a peptide corresponding to amino acids 125-140 of the putative second domain of the alpha-subunit sequence. All the inhibitory antibodies compete with 125I-15A5 for binding to the ch-alpha-protein, indicating that these antibodies recognize inhibitory epitopes that are either identical or sterically overlapping. Noninhibitory antibodies (i.e. 22E7) do not block 125I-15A5 binding to the ch-alpha-protein. These data suggest that antibodies binding to the predicted second domain of the alpha-subunit can inhibit IgE binding to the alpha-subunit, while antibodies binding at a distance from this site do not inhibit IgE binding. These inhibitory antibodies may block IgE binding to the ch-alpha-protein by direct overlap, steric inhibition, or induced conformational changes of the receptor contact points for IgE.
IgE与肥大细胞和嗜碱性粒细胞上的高亲和力Fcε受体(FcεRI)的结合是由四聚体受体复合物的α亚基介导的。基于序列同源性,50 kDa的α亚基是免疫球蛋白超家族蛋白质的成员,有两个预测的二硫键连接环。已鉴定出对人α亚基具有特异性的单克隆抗体,并将其分为两大类:抑制性抗体和非抑制性抗体。抑制性抗体(如15A5)可阻断125I-IgE与在中国仓鼠卵巢细胞上表达的重组嵌合α亚基(ch-α蛋白)的结合,并免疫沉淀125I标记的纯化ch-α蛋白。非抑制性抗体(如22E7)可免疫沉淀125I标记的ch-α蛋白以及与ch-α蛋白交联的125I-IgE可溶性复合物,但不阻断125I-IgE与在中国仓鼠卵巢细胞上表达的ch-α蛋白的结合。这两类抗体均与人嗜碱性粒细胞上存在的天然FcεRI结合,并诱导这些细胞释放组胺。抑制性抗体15A5特异性结合与α亚基序列假定第二结构域的氨基酸125-140相对应的肽段。所有抑制性抗体都与125I-15A5竞争与ch-α蛋白的结合,表明这些抗体识别的抑制性表位要么相同,要么空间重叠。非抑制性抗体(如22E7)不阻断12I-15A5与ch-α蛋白的结合。这些数据表明,与α亚基预测的第二结构域结合的抗体可抑制IgE与α亚基的结合,而在距该位点一定距离处结合的抗体则不抑制IgE结合。这些抑制性抗体可能通过直接重叠、空间抑制或诱导IgE受体接触点的构象变化来阻断IgE与ch-α蛋白的结合。